Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernhard Scheiner

Showing results (111-120 of 203) with videos related to

Pageof 21
Sort By:
Hepatology International|August 21, 2023
Von Willebrand factor processing in patients with advanced chronic liver disease and its relation to portal hypertension and clinical outcomeBenedikt Simbrunner, Ida Falk Villesen, Bernhard Scheiner, et al.
Alimentary Pharmacology & Therapeutics|September 21, 2024
Insulin-like growth factor-1 in cirrhosis is linked to hepatic dysfunction and fibrogenesis and predicts liver-related mortalityLukas Hartl, Michael Schwarz, Benedikt Simbrunner, et al.
Alimentary Pharmacology & Therapeutics|November 4, 2024
Letter: The Prognostic Role of IGF-1 in Chronic Liver Disease-Authors' ReplyLukas Hartl, Michael Schwarz, Benedikt Simbrunner, et al.
Hepatology International|December 8, 2020
Vitamin A levels reflect disease severity and portal hypertension in patients with cirrhosisBenedikt Simbrunner, Georg Semmler, Alexander Stadlmann, et al.
BMC Medicine|November 12, 2020
Serum keratin 19 (CYFRA21-1) links ductular reaction with portal hypertension and outcome of various advanced liver diseasesKarim Hamesch, Nurdan Guldiken, Mahmoud Aly, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 23, 2020
Impact of HSD17B13 rs72613567 genotype on hepatic decompensation and mortality in patients with portal hypertensionBernhard Scheiner, Albert F Stättermayer, Philipp Schwabl, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 25, 2022
Clinical significance of substantially elevated von Willebrand factor antigen levels in patients with advanced chronic liver diseaseKatharina Pomej, Bernhard Scheiner, Lorenz Balcar, et al.
Journal of Personalized Medicine|April 30, 2021
Influence of Genetic Variants on Disease Regression and Outcomes in HCV-Related Advanced Chronic Liver Disease after SVRGeorg Semmler, Teresa Binter, Karin Kozbial, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 12, 2022
Age-adjusted mortality and predictive value of liver chemistries in a Viennese cohort of COVID-19 patientsLukas Hartl, Katharina Haslinger, Martin Angerer, et al.
Gut|November 17, 2020
Amelioration of systemic inflammation in advanced chronic liver disease upon beta-blocker therapy translates into improved clinical outcomesMathias Jachs, Lukas Hartl, Dunja Schaufler, et al.
Pageof 21

Showing results (111-120 of 203) with videos related to

Sort By:
Pageof 21
Hepatology International|August 21, 2023
Von Willebrand factor processing in patients with advanced chronic liver disease and its relation to portal hypertension and clinical outcomeBenedikt Simbrunner, Ida Falk Villesen, Bernhard Scheiner, et al.
Alimentary Pharmacology & Therapeutics|September 21, 2024
Insulin-like growth factor-1 in cirrhosis is linked to hepatic dysfunction and fibrogenesis and predicts liver-related mortalityLukas Hartl, Michael Schwarz, Benedikt Simbrunner, et al.
Alimentary Pharmacology & Therapeutics|November 4, 2024
Letter: The Prognostic Role of IGF-1 in Chronic Liver Disease-Authors' ReplyLukas Hartl, Michael Schwarz, Benedikt Simbrunner, et al.
Hepatology International|December 8, 2020
Vitamin A levels reflect disease severity and portal hypertension in patients with cirrhosisBenedikt Simbrunner, Georg Semmler, Alexander Stadlmann, et al.
BMC Medicine|November 12, 2020
Serum keratin 19 (CYFRA21-1) links ductular reaction with portal hypertension and outcome of various advanced liver diseasesKarim Hamesch, Nurdan Guldiken, Mahmoud Aly, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 23, 2020
Impact of HSD17B13 rs72613567 genotype on hepatic decompensation and mortality in patients with portal hypertensionBernhard Scheiner, Albert F Stättermayer, Philipp Schwabl, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 25, 2022
Clinical significance of substantially elevated von Willebrand factor antigen levels in patients with advanced chronic liver diseaseKatharina Pomej, Bernhard Scheiner, Lorenz Balcar, et al.
Journal of Personalized Medicine|April 30, 2021
Influence of Genetic Variants on Disease Regression and Outcomes in HCV-Related Advanced Chronic Liver Disease after SVRGeorg Semmler, Teresa Binter, Karin Kozbial, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 12, 2022
Age-adjusted mortality and predictive value of liver chemistries in a Viennese cohort of COVID-19 patientsLukas Hartl, Katharina Haslinger, Martin Angerer, et al.
Gut|November 17, 2020
Amelioration of systemic inflammation in advanced chronic liver disease upon beta-blocker therapy translates into improved clinical outcomesMathias Jachs, Lukas Hartl, Dunja Schaufler, et al.
Pageof 21